Levothyroxine sodium pentahydrate is a pharmaceutical raw material consisting of the sodium salt of the thyroid hormone thyroxine (T4) in a hydrate form. It is primarily supplied to pharmaceutical manufacturers for use in the production of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 6106-07-6
Sodium levothyroxine hydrate
pharmaceutical raw material
Levothyroxine sodium
pharmaceutical raw material
Liothyronine sodium
pharmaceutical raw material
Scopolamine aminoxide hydrobromide
pharmaceutical raw material
Lidocaine hydrochloride monohydrate
pharmaceutical raw material
Paraxanthine
pharmaceutical raw material
DL-Mandelic acid
pharmaceutical raw material
L-thyroxine zwitterion
pharmaceutical raw material
sodium;(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate;pentahydrate
JMHCCAYJTTWMCX-QWPJCUCISA-M
C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)C[C@@H](C(=O)[O-])N.O.O.O.O.O.[Na+]